SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vasomedical Inc.
VASO 0.170-1.0%Dec 15 3:36 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Antonios Petropoulos who wrote (449)7/2/1997 9:47:00 AM
From: Jack Ucci   of 1605
 
Can anyone provide some insight on how this private placement will effect the behavior of vaso's stock price? Specifically what is the meaning of "a private placement of $3.0 million of 5% Series B Convertible Preferred Shares"? How many shares? What was the price of them? When are they convertible? I am not referring to the reasons given in the announcement.

Private placements can have a negative effect; eg if the price of the shares greatly undercut the current price of the stock and the money raised did not get used to significantly improve the bottom line. There then can be a large move toward the exits.

How can we obtain more particulars about this placement?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext